Robert E. Landry - Mar 27, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Robert E. Landry
Stock symbol
REGN
Transactions as of
Mar 27, 2023
Transactions value $
-$1,841,829
Form type
4
Date filed
3/29/2023, 04:07 PM
Previous filing
Feb 7, 2023
Next filing
Aug 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $306K +800 +2.49% $381.92 32.9K Mar 27, 2023 Direct F1
transaction REGN Common Stock Tax liability -$486K -589 -1.79% $825.17 32.3K Mar 27, 2023 Direct F1
transaction REGN Common Stock Options Exercise $1.14M +3K +9.28% $378.98 35.3K Mar 27, 2023 Direct F1
transaction REGN Common Stock Tax liability -$1.82M -2.2K -6.24% $825.17 33.1K Mar 27, 2023 Direct F1
transaction REGN Common Stock Sale -$32K -39 -0.12% $819.47 33.1K Mar 27, 2023 Direct F1, F2
transaction REGN Common Stock Sale -$41K -50 -0.15% $820.46 33K Mar 27, 2023 Direct F1, F3
transaction REGN Common Stock Sale -$39.4K -48 -0.15% $821.39 33K Mar 27, 2023 Direct F1, F4
transaction REGN Common Stock Sale -$14.8K -18 -0.05% $822.57 33K Mar 27, 2023 Direct F1, F5
transaction REGN Common Stock Sale -$3.3K -4 -0.01% $824.30 33K Mar 27, 2023 Direct F1
transaction REGN Common Stock Sale -$10.7K -13 -0.04% $825.59 32.9K Mar 27, 2023 Direct F1
transaction REGN Common Stock Sale -$3.32K -4 -0.01% $829.16 32.9K Mar 27, 2023 Direct F1
transaction REGN Common Stock Sale -$5.81K -7 -0.02% $830.01 32.9K Mar 27, 2023 Direct F1
transaction REGN Common Stock Sale -$8.19K -10 -0.03% $818.81 32.9K Mar 28, 2023 Direct F1
transaction REGN Common Stock Sale -$94.4K -115 -0.35% $820.85 32.8K Mar 28, 2023 Direct F1, F6
transaction REGN Common Stock Sale -$117K -142 -0.43% $821.40 32.7K Mar 28, 2023 Direct F1, F7
transaction REGN Common Stock Sale -$105K -128 -0.39% $822.67 32.5K Mar 28, 2023 Direct F1, F8
transaction REGN Common Stock Sale -$149K -181 -0.56% $823.60 32.4K Mar 28, 2023 Direct F1, F9
transaction REGN Common Stock Sale -$129K -157 -0.49% $824.54 32.2K Mar 28, 2023 Direct F1, F10
transaction REGN Common Stock Sale -$201K -243 -0.75% $825.37 32K Mar 28, 2023 Direct F1, F11
transaction REGN Common Stock Sale -$25.6K -31 -0.1% $826.36 31.9K Mar 28, 2023 Direct F1
holding REGN Common Stock 250 Mar 27, 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -12.86% $0.00 20.3K Mar 27, 2023 Common Stock 3K $378.98 Direct F1, F12
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -800 -100% $0.00* 0 Mar 27, 2023 Common Stock 800 $381.92 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.
F2 Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F9 Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F10 Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F11 Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
F12 The stock option award vests in four equal annual installments, commencing one year after the date of grant.